▶ 調査レポート

世界の乳児臨床栄養市場

• 英文タイトル:Global Market Study on Infant Clinical Nutrition: Increasing Push towards Optimized Child Nutrition in the Upcoming Years

Persistence Market Researchが調査・発行した産業分析レポートです。世界の乳児臨床栄養市場 / Global Market Study on Infant Clinical Nutrition: Increasing Push towards Optimized Child Nutrition in the Upcoming Years / MRC2303A119資料のイメージです。• レポートコード:MRC2303A119
• 出版社/出版日:Persistence Market Research / 2022年12月29日
• レポート形態:英文、PDF、159ページ
• 納品方法:Eメール
• 産業分類:食品
• 販売価格(消費税別)
  Single User¥710,500 (USD4,900)▷ お問い合わせ
  Site Licence¥1,102,000 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,537,000 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社発行の当調査レポートでは、世界の乳児臨床栄養市場の現状について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、価格分析、需要分析・予測、市場背景、市場構造分析、競争分析、仮定、調査手法などの構成でまとめております。セグメント分析では、製品タイプ別(牛乳系、大豆系、オーガニック、プロバイオティクス/プレバイオティクス)、投与経路別(経口投与、経腸投与、静脈内投与)、地域別(北米、中南米、ヨーロッパ、南アジア&太平洋、東アジア、中東/アフリカ)の情報が含まれています。なお、当市場の主要企業には、Abbott Laboratories、Baxter International、Nestle S.A.、Danone、Meiji Holdings Co., Ltd.、Fresenius SE & Co. KGaA、Reckitt Benckiser Group Plc、Perrigo Co. Plc、Ingredion Inc.、Solace Nutritionなどが含まれています。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・主要成功要因
・価格分析
・需要分析・予測
・市場背景

・世界の乳児臨床栄養市場規模:製品タイプ別
- 牛乳系乳児臨床栄養の市場規模
- 大豆系乳児臨床栄養の市場規模
- オーガニック乳児臨床栄養の市場規模
- プロバイオティクス/プレバイオティクス乳児臨床栄養の市場規模

・世界の乳児臨床栄養市場規模:投与経路別
- 経口投与の市場規模
- 経腸投与の市場規模
- 静脈内投与の市場規模

・世界の乳児臨床栄養市場規模:地域別
- 北米の乳児臨床栄養市場規模
- 中南米の乳児臨床栄養市場規模
- ヨーロッパの乳児臨床栄養市場規模
- 南アジア&太平洋の乳児臨床栄養市場規模
- 東アジアの乳児臨床栄養市場規模
- 中東/アフリカの乳児臨床栄養市場規模

・市場構造分析
・競争分析
・仮定
・調査手法

Infant Clinical Nutrition Market: Report Scope

A latest market report by Persistence Market Research on the global infant clinical nutrition market evaluates the opportunities and current market scenario, providing insights and updates about corresponding segments involved in the market for the forecast period of 2023-2033. The report provides detailed assessment of key market dynamics, and comprehensive information about the structure of the market. This study contains detailed insights into how the market is anticipated to grow during the forecast period of 2023-2033.

The primary objective of the report is to provide insights regarding opportunities in the market that are supporting the transformation of global businesses associated with infant clinical nutrition. It is very important to consider that, in an ever-wavering economy, we provide estimated (Y-o-Y) year-on-year growth rate in addition to compound annual growth rate (CAGR) for overall forecasts, to enable readers better understand the analysis and evaluation of the market, and to discover lucrative opportunities in this space.

This report also provides an estimate of market size and corresponding revenue forecasts carried out in terms of absolute $ opportunity. It also offers actionable insights based on the future trends in the market. Furthermore, new and emerging players in the global infant clinical nutrition market can make use of the information presented in the study for effective business decisions, which will provide momentum to their businesses as well as the global market.

The study is relevant for manufacturers, suppliers, distributors, and investors in the infant clinical nutrition market. All stakeholders, as well as industry experts, researchers, journalists, and business researchers can leverage the information and data represented in the report.

Key Market Segments

Persistence Market Research’s report on the global infant clinical nutrition market offers information divided into three segments – product type, route of administration and region.

Product Type

Milk-Based
Soy-Based
Organic
Probiotic/Prebiotic

Route of Administration

Oral administration
Enteral administration
Intravenous administration

Region

North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa

Key Questions Answered in Study

Which region will hold the highest market share over the forecast period?
Which region is experiencing the highest growth (CAGR)?
Which factors are impacting the global infant clinical nutrition market?
What are the global trends impacting the market?
What strategies must emerge players adopt to capture opportunities in various regions in the market?
What is the structure of the global infant clinical nutrition market?

Research Methodology

Persistence Market Research is committed to providing unbiased market research solutions to its clients. The company follows a robust methodology for the deduction of data included in this report. A unique research methodology is utilized to conduct extensive research on the global infant clinical nutrition market, and reach conclusions about the future growth factors of the market. The research methodology comprises primary research methods coupled with secondary research methods, which ensures the accuracy and reliability of the conclusions in this report.

A demand-side approach is followed to estimate the sales of target products, followed by an in-depth supply-side assessment of value generated, key trends, and events over a predefined period. This methodology is based on standard market structures, methods, and definitions that are based on inputs from local sources in over six regions – North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East & Africa which Persistence Market Research considers for segmenting the global market. Statistics, characteristics, and variances are collected at a regional level, aggregated at the same level, and then synthesized at a worldwide level, to create global market measurements. Our main sources of research include:

Primary Research
Secondary Research
Trade Research
Social Media Research

レポート目次

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

        3.1.1. Increasing Birth Rate with the Growing Number of Premature Births Creates Needs for Infant Nutrition Supplements

        3.1.2. Advancements in the Nutritional Modifications in the Infant Food Products to Boost the Market Growth

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption / Usage Analysis

    4.2. Product USPs / Features

    4.3. Strategic Promotional Strategies

5. Global Infant Clinical Nutrition Market – Pricing Analysis

    5.1. Regional Pricing Trend Analysis, 2017-2022

    5.2. Global Average Pricing Analysis Benchmark

6. Global Infant Clinical Nutrition Market Demand (in Value US$ Mn) Analysis 2018–2022 and Forecast, 2023–2033

    6.1. Historical Market Value (US$ Mn) Analysis, 2018–2022

    6.2. Current and Future Market Value (US$ Mn) Projections, 2023–2033

        6.2.1. Y-o-Y Growth Trend Analysis

        6.2.2. Absolute $ Opportunity Analysis

7. Market Background

    7.1. Macro-Economic Factors

        7.1.1. Global GDP Growth Outlook

        7.1.2. Global Food & Beverage industry Overview

        7.1.3. Global GDP and Infrastructure Investment

        7.1.4. International Trade

        7.1.5. Global Industry Outlook

    7.2. Forecast Factors – Relevance & Impact

        7.2.1. Top Companies Historical Growth

        7.2.2. GDP Growth forecast

        7.2.3. Manufacturing Industry forecast

        7.2.4. Global Urbanization Growth Outlook

        7.2.5. Business Climate

    7.3. Global Food and Beverage Industry Overview

    7.4. Global Dairy Industry Overview

    7.5. Supply Chain & Value-Chain Analysis

        7.5.1. Raw Material Suppliers

        7.5.2. Product Manufacturers

        7.5.3. Distribution Channel Industries

    7.6. Policy Developments and Regulatory Scenario

        7.6.1. The United States Food and Drug Administration (FDA)

        7.6.2. Canadian Food Inspection Agency

        7.6.3. European Food Safety Authority (EFSA)

        7.6.4. The Food Safety and Standards Authority of India (FSSAI)

        7.6.5. Ministry of Health, Labor and Welfare. (MHLW), Japan

        7.6.6. National Health Commission (NHC), China

        7.6.7. Food Standards Australia New Zealand (FSANZ)

    7.7. Market Dynamics

        7.7.1. Drivers

        7.7.2. Restraints

        7.7.3. Opportunity Analysis

    7.8. Global Supply Demand Analysis

8. Global Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033, by Product Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) By Product Type, 2018–2022

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2023–2033

        8.3.1. Milk-Based

        8.3.2. Soy-Based

        8.3.3. Organic

        8.3.4. Probiotic/Prebiotic

    8.4. Market Attractiveness Analysis By Product Type

9. Global Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033, By Route of Administration

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) and Volume Analysis By Route of Administration, 2018–2022

    9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Route of Administration, 2023–2033

        9.3.1. Oral administration

        9.3.2. Enteral administration

        9.3.3. Intravenous administration

    9.4. Market Attractiveness Analysis By Route of Administration

10. Global Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033, by Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2018–2022

    10.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2023–2033

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. South Asia and Pacific

        10.3.5. East Asia

        10.3.6. Middle East and Africa (MEA)

    10.4. Market Attractiveness Analysis By Region

11. North America Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033

    11.1. Introduction

    11.2. Pricing Analysis

    11.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2018–2022

    11.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2023–2033

        11.4.1. By Country

            11.4.1.1. U.S.

            11.4.1.2. Canada

        11.4.2. By Product Type

        11.4.3. By Route of Administration

    11.5. Market Attractiveness Analysis

        11.5.1. By Country

        11.5.2. By Product Type

        11.5.3. By Route of Administration

    11.6. Market Trends

    11.7. Key Market Participants – Intensity Mapping

    11.8. Drivers and Restraints – Impact Analysis

12. Latin America Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2018–2022

    12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2023–2033

        12.4.1. By Country

            12.4.1.1. Brazil

            12.4.1.2. Mexico

            12.4.1.3. Argentina

            12.4.1.4. Rest of Latin America

        12.4.2. By Product Type

        12.4.3. By Route of Administration

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Product Type

        12.5.3. By Route of Administration

    12.6. Market Trends

    12.7. Key Market Participants – Intensity Mapping

    12.8. Drivers and Restraints – Impact Analysis

13. Europe Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2018–2022

    13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2023–2033

        13.4.1. By Country

            13.4.1.1. Germany

            13.4.1.2. Italy

            13.4.1.3. France

            13.4.1.4. U.K.

            13.4.1.5. Spain

            13.4.1.6. BENELUX

            13.4.1.7. Russia

            13.4.1.8. Poland

            13.4.1.9. Rest of Europe

        13.4.2. By Product Type

        13.4.3. By Route of Administration

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product Type

        13.5.3. By Route of Administration

    13.6. Market Trends

    13.7. Key Market Participants – Intensity Mapping

    13.8. Drivers and Restraints – Impact Analysis

14. South Asia and Pacific Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2018–2022

    14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2023–2033

        14.4.1. By Country

            14.4.1.1. India

            14.4.1.2. ASEAN

            14.4.1.3. Oceania (Australia & New Zealand)

            14.4.1.4. Rest of South Asia & Pacific

        14.4.2. By Product Type

        14.4.3. By Route of Administration

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product Type

        14.5.3. By Route of Administration

    14.6. Market Trends

    14.7. Key Market Participants – Intensity Mapping

    14.8. Drivers and Restraints – Impact Analysis

15. East Asia Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2018–2022

    15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2023–2033

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

        15.4.2. By Product Type

        15.4.3. By Route of Administration

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product Type

        15.5.3. By Route of Administration

    15.6. Market Trends

    15.7. Key Market Participants – Intensity Mapping

    15.8. Drivers and Restraints – Impact Analysis

16. Middle East and Africa Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2018–2022

    16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2023–2033

        16.4.1. By Country

            16.4.1.1. GCC Countries

            16.4.1.2. Turkey

            16.4.1.3. Northern Africa

            16.4.1.4. South Africa

            16.4.1.5. Rest of Middle East and Africa

        16.4.2. By Product Type

        16.4.3. By Route of Administration

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product Type

        16.5.3. By Route of Administration

    16.6. Market Trends

    16.7. Key Market Participants – Intensity Mapping

    16.8. Drivers and Restraints – Impact Analysis

17. Country Wise Infant Clinical Nutrition Market Analysis, 2023

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. U.S. Infant Clinical Nutrition Market Analysis

        17.2.1. By Product Type

        17.2.2. By Route of Administration

    17.3. Canada Infant Clinical Nutrition Market Analysis

        17.3.1. By Product Type

        17.3.2. By Route of Administration

    17.4. Mexico Infant Clinical Nutrition Market Analysis

        17.4.1. By Product Type

        17.4.2. By Route of Administration

    17.5. Brazil Infant Clinical Nutrition Market Analysis

        17.5.1. By Product Type

        17.5.2. By Route of Administration

    17.6. Argentina Infant Clinical Nutrition Market Analysis

        17.6.1. By Product Type

        17.6.2. By Route of Administration

    17.7. Germany Infant Clinical Nutrition Market Analysis

        17.7.1. By Product Type

        17.7.2. By Route of Administration

    17.8. Italy Infant Clinical Nutrition Market Analysis

        17.8.1. By Product Type

        17.8.2. By Route of Administration

    17.9. France Infant Clinical Nutrition Market Analysis

        17.9.1. By Product Type

        17.9.2. By Route of Administration

    17.10. U.K. Infant Clinical Nutrition Market Analysis

        17.10.1. By Product Type

        17.10.2. By Route of Administration

    17.11. Spain Infant Clinical Nutrition Market Analysis

        17.11.1. By Product Type

        17.11.2. By Route of Administration

    17.12. Poland Infant Clinical Nutrition Market Analysis

        17.12.1. By Product Type

        17.12.2. By Route of Administration

    17.13. Russia Infant Clinical Nutrition Market Analysis

        17.13.1. By Product Type

        17.13.2. By Route of Administration

    17.14. China Infant Clinical Nutrition Market Analysis

        17.14.1. By Product Type

        17.14.2. By Route of Administration

    17.15. Japan Infant Clinical Nutrition Market Analysis

        17.15.1. By Product Type

        17.15.2. By Route of Administration

    17.16. S. Korea Infant Clinical Nutrition Market Analysis

        17.16.1. By Product Type

        17.16.2. By Route of Administration

    17.17. India Infant Clinical Nutrition Market Analysis

        17.17.1. By Product Type

        17.17.2. By Route of Administration

    17.18. Oceania (Australia and New Zealand) Infant Clinical Nutrition Market Analysis

        17.18.1. By Product Type

        17.18.2. By Route of Administration

    17.19. Turkey Infant Clinical Nutrition Market Analysis

        17.19.1. By Product Type

        17.19.2. By Route of Administration

    17.20. South Africa Infant Clinical Nutrition Market Analysis

        17.20.1. By Product Type

        17.20.2. By Route of Administration

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies (Infant Clinical Nutrition)

    18.2. Market Share Analysis of Top Players

    18.3. Market Presence Analysis

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive

        19.3.1. Abbott Laboratories

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.1.4. Sales Footprint

            19.3.1.5. Strategy Overview

        19.3.2. Baxter International

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.2.4. Sales Footprint

            19.3.2.5. Strategy Overview

        19.3.3. Nestle S.A.

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.3.4. Sales Footprint

            19.3.3.5. Strategy Overview

        19.3.4. Danone

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.4.4. Sales Footprint

            19.3.4.5. Strategy Overview

        19.3.5. Meiji Holdings Co., Ltd.

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.5.4. Sales Footprint

            19.3.5.5. Strategy Overview

        19.3.6. Fresenius SE & Co. KGaA

            19.3.6.1. Overview

            19.3.6.2. Product Portfolio

            19.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.6.4. Sales Footprint

            19.3.6.5. Strategy Overview

        19.3.7. Reckitt Benckiser Group Plc

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.7.4. Sales Footprint

            19.3.7.5. Strategy Overview

        19.3.8. Perrigo Co. Plc

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.8.4. Sales Footprint

            19.3.8.5. Strategy Overview

        19.3.9. Ingredion Inc.

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.9.4. Sales Footprint

            19.3.9.5. Strategy Overview

        19.3.10. Solace Nutrition

            19.3.10.1. Overview

            19.3.10.2. Product Portfolio

            19.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.10.4. Sales Footprint

            19.3.10.5. Strategy Overview

        19.3.11. Others ( on Additional Request)

            19.3.11.1. Overview

            19.3.11.2. Product Portfolio

            19.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            19.3.11.4. Sales Footprint

            19.3.11.5. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology